MYC and acute lymphoblastic leukemia: When T- and B-ALL samples from a single patient cohort (GSE18497, 41 patients) were stratified using the MYC p19ARF−/− gene signature, patients who expressed high levels of the genes within this gene signature demonstrated significantly worse relapse-free survival (RFS, p = 0.031) (Figure 7B).